Back
Denali Therapeutics Stock Price Chart
20 Most Hated Stocks on Wall Street
Click here to see the full list and protect yourself before it's too late.
Sell
24
DNLI
Denali Therapeutics
Last Price:
16.60
Seasonality Move:
12.16%
7 Day Trial
ALL ACCESS PASS
$
7
Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!
Act now for your path to extra income!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
Denali Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.98 | Sell |
| 20-day SMA: | 19.11 | Sell |
| 50-day SMA: | 19.19 | Sell |
| 200-day SMA: | 21.11 | Sell |
| 8-day EMA: | 17.76 | Sell |
| 20-day EMA: | 18.69 | Sell |
| 50-day EMA: | 19.08 | Sell |
| 200-day EMA: | 21.17 | Sell |
Denali Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 33.92 | Sell |
| Chaikin Money Flow: | -630624 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.14 - 20.58) | Sell |
| Bollinger Bands (100): | (17.27 - 20.99) | Sell |
Denali Therapeutics Technical Analysis
| Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics Stock
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 16.60 while DNLI 8-day simple moving average is 17.98, which is a Sell signal.
- The stock price of DNLI is 16.60 while Denali Therapeutics 20-day SMA is 19.11, which makes it a Sell.
- Denali Therapeutics 50-day simple moving average is 19.19 while DNLI share price is 16.60, making it a Sell technically.
- DNLI stock price is 16.60 and Denali Therapeutics 200-day simple moving average is 21.11, creating a Sell signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
24
Denali Therapeutics (DNLI)
is a Sell
Is Denali Therapeutics a Buy or a Sell?
-
Denali Therapeutics stock is rated a Sell
The current Denali Therapeutics [DNLI] share price is $16.60. The Score for DNLI is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics Stock Info
Market Cap:
2.31B
Price in USD:
16.60
Share Volume:
891.57K
Denali Therapeutics 52-Week Range
52-Week High:
33.31
52-Week Low:
15.45
Sell
24
Denali Therapeutics (DNLI)
is a Sell
Denali Therapeutics Share Price Forecast
-
What is the Denali Therapeutics stock price today?
The Denali Therapeutics stock price is 16.60 USD today. -
Will DNLI stock go up or go down?
Denali Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Denali Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics is overvalued.
Is Denali Therapeutics Stock a Buy?
- Denali Therapeutics share price is 16.60 while DNLI 8-day exponential moving average is 17.76, which is a Sell signal.
- The stock price of DNLI is 16.60 while Denali Therapeutics 20-day EMA is 18.69, which makes it a Sell.
- Denali Therapeutics 50-day exponential moving average is 19.08 while DNLI share price is 16.60, making it a Sell technically.
- DNLI stock price is 16.60 and Denali Therapeutics 200-day simple moving average is 21.17, creating a Sell signal.
Fundamental Analysis of Denali Therapeutics
Is Denali Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.49 per share, and an increase next year of $0.10 per share.
Technical Analysis of Denali Therapeutics
Should I short Denali Therapeutics stock?
- DNLI Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting Denali Therapeutics is a Sell
- Denali Therapeutics Relative Strength Index (RSI) is 33.92, which suggest Denali Therapeutics is oversold
- The Bollinger Bands (25) for Denali Therapeutics is (18.14 - 20.58), which suggest Denali Therapeutics is a Sell
- The Bollinger Bands (100) for Denali Therapeutics is (17.27 - 20.99), which suggest Denali Therapeutics is a Sell
* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.